Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Plasma protein N-glycan signatures of type 2 diabetes.

Dotz V, Lemmers RFH, Reiding KR, Hipgrave Ederveen AL, Lieverse AG, Mulder MT, Sijbrands EJG, Wuhrer M, van Hoek M.

Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2613-2622. doi: 10.1016/j.bbagen.2018.08.005. Epub 2018 Aug 6.

PMID:
30251656
2.

Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer.

Dieleman EMT, Uitterhoeve ALJ, van Hoek MW, van Os RM, Wiersma J, Koolen MGJ, Kolff MW, Koning CCE, Adam JA, Verberne HJ, Annema JT, Rasch CRN.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):543-551. doi: 10.1016/j.ijrobp.2018.07.188. Epub 2018 Jul 25.

3.

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.

Barf T, Covey T, Izumi R, van de Kar B, Gulrajani M, van Lith B, van Hoek M, de Zwart E, Mittag D, Demont D, Verkaik S, Krantz F, Pearson PG, Ulrich R, Kaptein A.

J Pharmacol Exp Ther. 2017 Nov;363(2):240-252. doi: 10.1124/jpet.117.242909. Epub 2017 Sep 7.

PMID:
28882879
4.

IgG glycan patterns are associated with type 2 diabetes in independent European populations.

Lemmers RFH, Vilaj M, Urda D, Agakov F, Šimurina M, Klaric L, Rudan I, Campbell H, Hayward C, Wilson JF, Lieverse AG, Gornik O, Sijbrands EJG, Lauc G, van Hoek M.

Biochim Biophys Acta Gen Subj. 2017 Sep;1861(9):2240-2249. doi: 10.1016/j.bbagen.2017.06.020. Epub 2017 Jun 28.

PMID:
28668296
5.

Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound.

M C Chung E, Dean SN, Propst CN, Bishop BM, van Hoek ML.

NPJ Biofilms Microbiomes. 2017 Apr 11;3:9. doi: 10.1038/s41522-017-0017-2. eCollection 2017.

6.

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes.

van Herpt TTW, Lemmers RFH, van Hoek M, Langendonk JG, Erdtsieck RJ, Bravenboer B, Lucas A, Mulder MT, Haak HR, Lieverse AG, Sijbrands EJG.

Diabetol Metab Syndr. 2017 Jun 19;9:47. doi: 10.1186/s13098-017-0245-x. eCollection 2017.

7.

Contemplative Listening in Moral Issues: Moral Counseling Redefined in Principles and Method.

de Groot J, van Hoek MEC.

J Pastoral Care Counsel. 2017 Jun;71(2):106-113. doi: 10.1177/1542305017708155.

8.

[Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors].

Zandee WT, Alsma J, Birkenhäger TK, den Meiracker AHV, van Hoek M, Versmissen J.

Tijdschr Psychiatr. 2017;59(6):366-371. Dutch.

9.

The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review.

Lemmers RFH, van Hoek M, Lieverse AG, Verhoeven AJM, Sijbrands EJG, Mulder MT.

J Clin Lipidol. 2017 May - Jun;11(3):712-724.e5. doi: 10.1016/j.jacl.2017.03.013. Epub 2017 Mar 31. Review.

PMID:
28442299
10.

Cathelicidin peptide rescues G. mellonella infected with B. anthracis.

Blower RJ, Popov SG, van Hoek ML.

Virulence. 2018 Jan 1;9(1):287-293. doi: 10.1080/21505594.2017.1293227. Epub 2017 Mar 8. No abstract available.

11.

Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo Dragon) by Large-Scale Analyses and De-Novo-Assisted Sequencing Using Electron-Transfer Dissociation Mass Spectrometry.

Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML.

J Proteome Res. 2017 Apr 7;16(4):1470-1482. doi: 10.1021/acs.jproteome.6b00857. Epub 2017 Feb 24.

PMID:
28164707
12.

Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.

Barksdale SM, Hrifko EJ, van Hoek ML.

Dev Comp Immunol. 2017 May;70:135-144. doi: 10.1016/j.dci.2017.01.011. Epub 2017 Jan 13.

PMID:
28089718
13.

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.

de Vries PS, van Herpt TT, Ligthart S, Hofman A, Ikram MA, van Hoek M, Sijbrands EJ, Franco OH, de Maat MP, Leebeek FW, Dehghan A.

Diabetologia. 2017 Feb;60(2):280-286. doi: 10.1007/s00125-016-4139-5. Epub 2016 Oct 27.

14.

Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.

Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.

BMC Microbiol. 2016 Aug 19;16(1):189. doi: 10.1186/s12866-016-0799-z.

15.

Request for organ donation without donor registration: a qualitative study of the perspectives of bereaved relatives.

de Groot J, van Hoek M, Hoedemaekers C, Hoitsma A, Schilderman H, Smeets W, Vernooij-Dassen M, van Leeuwen E.

BMC Med Ethics. 2016 Jul 11;17(1):38. doi: 10.1186/s12910-016-0120-6.

16.

Francisella philomiragia Infection and Lethality in Mammalian Tissue Culture Cell Models, Galleria mellonella, and BALB/c Mice.

Propst CN, Pylypko SL, Blower RJ, Ahmad S, Mansoor M, van Hoek ML.

Front Microbiol. 2016 May 24;7:696. doi: 10.3389/fmicb.2016.00696. eCollection 2016.

17.

Antimicrobial activity of mosquito cecropin peptides against Francisella.

Kaushal A, Gupta K, Shah R, van Hoek ML.

Dev Comp Immunol. 2016 Oct;63:171-80. doi: 10.1016/j.dci.2016.05.018. Epub 2016 May 26.

PMID:
27235883
18.

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.

van Herpt TT, Dehghan A, van Hoek M, Ikram MA, Hofman A, Sijbrands EJ, Franco OH.

Cardiovasc Diabetol. 2016 Apr 27;15:69. doi: 10.1186/s12933-016-0387-4.

19.

Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection.

Propst CN, Nwabueze AO, Kanev IL, Pepin RE, Gutting BW, Morozov VN, van Hoek ML.

J Nanobiotechnology. 2016 Apr 18;14:29. doi: 10.1186/s12951-016-0182-0.

20.

Potentiation of Francisella Resistance to Conventional Antibiotics through Small Molecule Adjuvants.

Stephens MD, Hubble VB, Ernst RK, van Hoek ML, Melander RJ, Cavanagh J, Melander C.

Medchemcomm. 2016 Jan 1;7(1):128-131. Epub 2015 Sep 30.

21.

Characterization of Cimex lectularius (bedbug) defensin peptide and its antimicrobial activity against human skin microflora.

Kaushal A, Gupta K, van Hoek ML.

Biochem Biophys Res Commun. 2016 Feb 19;470(4):955-60. doi: 10.1016/j.bbrc.2016.01.100. Epub 2016 Jan 21.

PMID:
26802465
22.

Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.

Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, van Hoek M, Sijbrands EJ, Franco OH, Dehghan A.

Lancet Diabetes Endocrinol. 2016 Jan;4(1):44-51. doi: 10.1016/S2213-8587(15)00362-9. Epub 2015 Nov 11.

PMID:
26575606
23.

Extracellular vesicles from infected cells: potential for direct pathogenesis.

Schwab A, Meyering SS, Lepene B, Iordanskiy S, van Hoek ML, Hakami RM, Kashanchi F.

Front Microbiol. 2015 Oct 20;6:1132. doi: 10.3389/fmicb.2015.01132. eCollection 2015. Review.

24.

Decision making on organ donation: the dilemmas of relatives of potential brain dead donors.

de Groot J, van Hoek M, Hoedemaekers C, Hoitsma A, Smeets W, Vernooij-Dassen M, van Leeuwen E.

BMC Med Ethics. 2015 Sep 17;16(1):64. doi: 10.1186/s12910-015-0057-1. Review.

25.

Large Scale Discovery and De Novo-Assisted Sequencing of Cationic Antimicrobial Peptides (CAMPs) by Microparticle Capture and Electron-Transfer Dissociation (ETD) Mass Spectrometry.

Juba ML, Russo PS, Devine M, Barksdale S, Rodriguez C, Vliet KA, Schnur JM, van Hoek ML, Bishop BM.

J Proteome Res. 2015 Oct 2;14(10):4282-95. doi: 10.1021/acs.jproteome.5b00447. Epub 2015 Sep 23.

PMID:
26327436
26.

Cardiovascular disease prevention: Mind the gap...

van Hoek M.

Neth J Med. 2015 Aug;73(7):308-9. No abstract available.

27.

Burkholderia Diffusible Signal Factor Signals to Francisella novicida To Disperse Biofilm and Increase Siderophore Production.

Dean SN, Chung MC, van Hoek ML.

Appl Environ Microbiol. 2015 Oct;81(20):7057-66. doi: 10.1128/AEM.02165-15. Epub 2015 Jul 31.

28.

Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.

Blower RJ, Barksdale SM, van Hoek ML.

PLoS Negl Trop Dis. 2015 Jul 21;9(7):e0003862. doi: 10.1371/journal.pntd.0003862. eCollection 2015.

29.

Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37.

Chung MC, Dean SN, van Hoek ML.

Biochem J. 2015 Sep 1;470(2):243-53. doi: 10.1042/BJ20150432. Epub 2015 Jul 17.

PMID:
26188040
31.

Analysis of mixed biofilm (Staphylococcus aureus and Pseudomonas aeruginosa) by laser ablation electrospray ionization mass spectrometry.

Dean SN, Walsh C, Goodman H, van Hoek ML.

Biofouling. 2015;31(2):151-61. doi: 10.1080/08927014.2015.1011067.

PMID:
25672229
32.

Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.

Bishop BM, Juba ML, Devine MC, Barksdale SM, Rodriguez CA, Chung MC, Russo PS, Vliet KA, Schnur JM, van Hoek ML.

PLoS One. 2015 Feb 11;10(2):e0117394. doi: 10.1371/journal.pone.0117394. eCollection 2015.

33.
34.

Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa.

Ulrey RK, Barksdale SM, Zhou W, van Hoek ML.

BMC Complement Altern Med. 2014 Dec 16;14:499. doi: 10.1186/1472-6882-14-499.

35.

Remaining symptoms in half the children treated for milk allergy.

Petrus NC, Schoemaker AF, van Hoek MW, Jansen L, Jansen-van der Weide MC, van Aalderen WM, Sprikkelman AB.

Eur J Pediatr. 2015 Jun;174(6):759-65. doi: 10.1007/s00431-014-2456-6. Epub 2014 Nov 22.

PMID:
25416174
36.

Common variants in PCSK1 influence blood pressure and body mass index.

Gu Q, Yazdanpanah M, van Hoek M, Hofman A, Gao X, de Rooij FW, Sijbrands EJ.

J Hum Hypertens. 2015 Feb;29(2):82-6. doi: 10.1038/jhh.2014.59. Epub 2014 Jul 17.

PMID:
25031086
37.

A genetic variant in SLC6A20 is associated with Type 2 diabetes in white-European and Chinese populations.

Ling Y, van Herpt TT, van Hoek M, Dehghan A, Hofman A, Uitterlinden AG, Jiang S, Lieverse AG, Bravenboer B, Lu D, van Duijn CM, Gao X, Sijbrands EJ.

Diabet Med. 2014 Nov;31(11):1350-6. doi: 10.1111/dme.12528. Epub 2014 Aug 12.

PMID:
24958070
38.

Antimicrobial peptides in reptiles.

van Hoek ML.

Pharmaceuticals (Basel). 2014 Jun 10;7(6):723-53. doi: 10.3390/ph7060723.

39.

Chitinases are negative regulators of Francisella novicida biofilms.

Chung MC, Dean S, Marakasova ES, Nwabueze AO, van Hoek ML.

PLoS One. 2014 Mar 24;9(3):e93119. doi: 10.1371/journal.pone.0093119. eCollection 2014.

40.

The carrying pigeons of the cell: exosomes and their role in infectious diseases caused by human pathogens.

Fleming A, Sampey G, Chung MC, Bailey C, van Hoek ML, Kashanchi F, Hakami RM.

Pathog Dis. 2014 Jul;71(2):109-20. doi: 10.1111/2049-632X.12135. Epub 2014 Feb 24. Review.

PMID:
24449527
41.

Hype and expectations in tissue engineering.

Oerlemans AJ, van Hoek ME, van Leeuwen E, Dekkers WJ.

Regen Med. 2014 Jan;9(1):113-22. doi: 10.2217/rme.13.89. Review.

PMID:
24351011
42.

Biofilms: an advancement in our understanding of Francisella species.

van Hoek ML.

Virulence. 2013 Nov 15;4(8):833-46. doi: 10.4161/viru.27023. Epub 2013 Nov 12. Review.

43.

[Prenylation: from bacteria to eukaryotes].

Marakasova ES, Akhmatova NK, Amaya M, Eisenhaber B, Eisenhaber F, van Hoek ML, Baranova AV.

Mol Biol (Mosk). 2013 Sep-Oct;47(5):717-30. Review. Russian.

44.

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.

Duplantier AJ, van Hoek ML.

Front Immunol. 2013 Jul 3;4:143. doi: 10.3389/fimmu.2013.00143. eCollection 2013.

45.

Cigarette smoke extract induces differential expression levels of beta-defensin peptides in human alveolar epithelial cells.

Pierson T, Learmonth-Pierson S, Pinto D, van Hoek ML.

Tob Induc Dis. 2013 Apr 29;11(1):10. doi: 10.1186/1617-9625-11-10.

46.

Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.

Bradburne CE, Verhoeven AB, Manyam GC, Chaudhry SA, Chang EL, Thach DC, Bailey CL, van Hoek ML.

J Biol Chem. 2013 Apr 12;288(15):10780-91. doi: 10.1074/jbc.M112.362178. Epub 2013 Jan 15.

47.

Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Oerlemans AJ, van Hoek ME, van Leeuwen E, van der Burg S, Dekkers WJ.

Sci Eng Ethics. 2013 Sep;19(3):963-81. doi: 10.1007/s11948-012-9419-y. Epub 2012 Nov 15.

PMID:
23229374
48.

Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy.

McKenney ES, Sargent M, Khan H, Uh E, Jackson ER, San Jose G, Couch RD, Dowd CS, van Hoek ML.

PLoS One. 2012;7(10):e38167. doi: 10.1371/journal.pone.0038167. Epub 2012 Oct 15.

49.

Resistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter.

Mackie RS, McKenney ES, van Hoek ML.

Front Microbiol. 2012 Aug 9;3:226. doi: 10.3389/fmicb.2012.00226. eCollection 2012.

50.

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.

Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Kähönen M, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, Böhringer S, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB; DIAGRAM+ Consortium; MAGIC Consortium; GLGC Investigators; MuTHER Consortium, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Lehtimäki T, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Barroso I, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Orrù M, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Seedorf U, Sharp SJ, Shields B, Sigurðsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tönjes A, Uitterlinden AG, van Dijk KW, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Ward KL, Watkins H, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC; DIAGRAM Consortium; GIANT Consortium; Global B Pgen Consortium, Borecki IB, Meneton P, Magnusson PK, Nathan DM, Williams GH, Silander K, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Serrano-Ríos M, Lind L, Palmer LJ, Hu FB 1st, Franks PW, Ebrahim S, Marmot M, Kao WH, Pramstaller PP, Wright AF, Stumvoll M, Hamsten A; Procardis Consortium, Buchanan TA, Valle TT, Rotter JI, Penninx BW, Boomsma DI, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Peltonen L, Mooser V, Sladek R; MAGIC investigators; GLGC Consortium, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Chasman DI, Johansen CT, Fouchier SW, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Feitosa MF, Orho-Melander M, Melander O, Li X, Li M, Cho YS, Go MJ, Kim YJ, Lee JY, Park T, Kim K, Sim X, Ong RT, Croteau-Chonka DC, Lange LA, Smith JD, Ziegler A, Zhang W, Zee RY, Whitfield JB, Thompson JR, Surakka I, Spector TD, Smit JH, Sinisalo J, Scott J, Saharinen J, Sabatti C, Rose LM, Roberts R, Rieder M, Parker AN, Pare G, O'Donnell CJ, Nieminen MS, Nickerson DA, Montgomery GW, McArdle W, Masson D, Martin NG, Marroni F, Lucas G, Luben R, Lokki ML, Lettre G, Launer LJ, Lakatta EG, Laaksonen R, Kyvik KO, König IR, Khaw KT, Kaplan LM, Johansson Å, Janssens AC, Igl W, Hovingh GK, Hengstenberg C, Havulinna AS, Hastie ND, Harris TB, Haritunians T, Hall AS, Groop LC, Gonzalez E, Freimer NB, Erdmann J, Ejebe KG, Döring A, Dominiczak AF, Demissie S, Deloukas P, de Faire U, Crawford G, Chen YD, Caulfield MJ, Boekholdt SM, Assimes TL, Quertermous T, Seielstad M, Wong TY, Tai ES, Feranil AB, Kuzawa CW, Taylor HA Jr, Gabriel SB, Holm H, Gudnason V, Krauss RM, Ordovas JM, Munroe PB, Kooner JS, Tall AR, Hegele RA, Kastelein JJ, Schadt EE, Strachan DP, Reilly MP, Samani NJ, Schunkert H, Cupples LA, Sandhu MS, Ridker PM, Rader DJ, Kathiresan S.

PLoS Genet. 2012;8(3):e1002607. doi: 10.1371/journal.pgen.1002607. Epub 2012 Mar 29.

Supplemental Content

Loading ...
Support Center